NCT00075270 arm group 3f237303121a9d19106f8a7fd915e494 [clinicaltrials_resource:NCT00075270/arm-group/3f237303121a9d19106f8a7fd915e494]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00075270 arm group 3f237303121a9d19106f8a7fd915e494 [clinicaltrials_resource:NCT00075270/arm-group/3f237303121a9d19106f8a7fd915e494]
Bio2RDF identifier
NCT00075270/arm-group/3f237303121a9d19106f8a7fd915e494
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 237303121a9d19106f8a7fd915e494
description [clinicaltrials_vocabulary:description]
Paclitaxel 175 mg/m Intravenously over 3 hours ever 3 weeks and Placebo
identifier
clinicaltrials_resource:NCT00075270/arm-group/3f237303121a9d19106f8a7fd915e494
title
NCT00075270 arm group 3f237303121a9d19106f8a7fd915e494
@en
type
label
NCT00075270 arm group 3f237303 ...... 37303121a9d19106f8a7fd915e494]
@en